Abstract
Hypertension (HTN) is a major independent risk factor for the development of stroke, coronary artery disease (CAD), peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD). HTN is a growing public health problem in Oman, almost certainly the most prevalent modifiable risk factor for cardiovascular disease (CVD). The risk of CVD in patients with HTN can be greatly reduced with lifestyle modifications and effective antihypertensive therapy. Randomized trials have shown that blood pressure (BP) lowering produces rapid reductions in CV risk. Several studies have shown that the majority of the hypertensive patients remain uncontrolled. It is well established that the observed poor control of the disease is not only related to poor adherence to medications, but also to limited awareness and adherence to evidence-based management of hypertension among physicians. Several guidelines for the management of patients with hypertension have been published. However, the aim of this document is to provide the busy physicians in Oman with more concise and direct approach towards implementing these guidelines into clinical practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281.
Weber MA, Schiffrin EL, White WB, et al. Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32(1):3–15.
Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.
James PA, Oparil S, Carter BL, Cushman WC, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507.
Dasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardio. 2014;30(5):485–501.
Weir MR, Hanes DS, Klassen DK. Antihypertensive Drugs. In: Taal MW, Chertow GM, Marsden PA, et al., editors. Brenner and Rector’s the kidney. 9th ed. Philadelphia: Saunders Elsevier; 2012.
Kaplan NM, Victor RG, editors. Kaplan’s clinical hypertension. 11th ed. USA: Lippincott Williams Wilkins; 2014.
Schmieder RE, Volpe M, Waeber B, Ruilope LM. A guide for easy- and difficult-to-treat hypertension. Int J Cardiol. 2014;172:17–22.
Al Riyami A, Attia Abd Elaty M, Morsi M, et al. Oman World Health Survey: part 1—methodology, sociodemographic profile and epidemiology of non-communicable diseases in Oman. Oman Med J. 2012;27(5):425–43.
Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.
Stessen M, Kuhle C, Hensrad D, et al. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:2245–54.
Grossman E, Messerli F. Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med. 2012;125:14–22.
Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008;52:1749–57.
Kaplan NM, Cooper O, Victor RG. Hypertension Therapy. In: Rosendorff C, editor. Essential cardiology: principles and practice. 3rd ed. New York: Springer Science + Business Media; 2013.
Author information
Authors and Affiliations
Corresponding author
Additional information
Developed in Collaboration with Committee for Improving Cardiology Services and Directorate of Non-communicable Diseases Surveillance and Control, Ministry of Health, Sultanate of Oman.
Rights and permissions
About this article
Cite this article
El-Deeb, M.H., Sulaiman, K.J., Al-Riyami, A.A. et al. 2015 Oman Heart Association Guidelines for the Management of Hypertension. High Blood Press Cardiovasc Prev 22, 83–97 (2015). https://doi.org/10.1007/s40292-014-0074-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-014-0074-z